ENDRA Life Sciences Inc. Common Stock NDRA

$4.47 +0.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q QUARTERLY REPORT 2026-08-14 View →
8-K CURRENT REPORT 2026-07-09 View →
8-K CURRENT REPORT 2026-06-26 View →
8-K CURRENT REPORT 2026-06-25 View →
8-K CURRENT REPORT 2026-05-28 View →
10-Q QUARTERLY REPORT 2026-05-15 View →
8-K CURRENT REPORT 2026-04-21 View →
10-K ANNUAL REPORT 2026-03-31 View →
8-K CURRENT REPORT 2026-03-31 View →
8-K CURRENT REPORT 2026-03-25 View →
4 4 2026-03-04 View →
4 4 2026-03-04 View →
4 4 2026-01-23 View →
4 4 2026-01-23 View →
4 4 2026-01-23 View →
4 4 2026-01-23 View →
4 4 2026-01-23 View →
8-K CURRENT REPORT 2025-12-15 View →
8-K CURRENT REPORT 2025-11-28 View →
8-K CURRENT REPORT 2025-11-14 View →
10-Q QUARTERLY REPORT 2025-11-14 View →
S-3 REGISTRATION STATEMENT 2025-11-06 View →
8-K CURRENT REPORT 2025-10-30 View →
424B5 PROSPECTUS SUPPLEMENT 2025-10-30 View →
DEF 14A DEF 14A 2025-10-28 View →
8-K FORM 8-K 2025-10-23 View →
4 4 2025-10-15 View →
8-K FORM 8-K 2025-10-15 View →
10-Q FORM 10-Q 2025-08-14 View →
8-K FORM 8-K 2025-07-23 View →
8-K FORM 8-K 2025-07-09 View →
S-1 FORM S-1 2025-07-09 View →
4 4 2025-07-01 View →
4 4 2025-07-01 View →
4 4 2025-07-01 View →
8-K FORM 8-K 2025-06-11 View →
8-K FORM 8-K 2025-05-30 View →
10-Q FORM 10-Q 2025-05-15 View →
8-K FORM 8-K 2025-05-15 View →
10-K FORM 10-K 2025-03-31 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.47
Market Cap
$5.68 million
52-Week Range
$2.96 – $9.85
Average Volume
25K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.